 | Up a level |
Harter, P., Baumann, K., Heimbach, A., Reuss, A., Jackisch, C., Hauke, J., Park-Simon, T. W., Richters, L., Hanker, L., Kroeber, S., Pfisterer, J., Gevensleben, H., Schnelzer, A., Dietrich, D., Schneider, S., Kommoss, S., Marme, F., Prieske, K., Schmutzler, R. and Hahnen, E. (2016). Mutations of risk genes for ovarian cancer in consecutive ovarian cancer patients (AGO TR-1 study). Int. J. Gynecol. Cancer, 26. S. 81 - 83. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1525-1438
Heimbach, A., Hauke, J., Richters, L., Kroeber, S., Altmueller, J., Becker, C., Thiele, H., Nuernberg, P., Bluemcke, B., Neidhardt, G., Riehm, K., Schmutzler, R. and Hahnen, E. (2016). TruRisk (R) based next-generation sequencing reveals a high prevalence of deleterious ATM mutations in BRCA1/2-negative breast and ovarian cancer families. Oncol. Res. Treat., 39. S. 52 - 53. BASEL: KARGER. ISSN 2296-5262
Marme, F., Harter, P., Hauke, J., Heitz, F., Reuss, A., Kommoss, S., Heimbach, A., Prieske, K., Richters, L., Burges, A., Neidhardt, G., de Gregorio, N., El-Balat, A., Hilpert, F., Meier, W., Heubner, M., Kast, K., Braicu, I., Hahnen, E. and Schmutzler, R. (2016). Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1). Int. J. Gynecol. Cancer, 26. S. 194 - 196. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1525-1438
Richters, L., Schouten, P. C., Park-Simon, T-W., Hauke, J., Hanker, L., Dietrich, D., Pfisterer, J., Krockenberger, M., Kluin, R., Schnelzer, A., du Bois, A., Kommoss, S., Heimbach, A., Schmidt, S., Marme, F., Prieske, K., Linn, S. C., Schmutzler, R. K., Harter, P. and Hahnen, E. (2018). BRCA-like classification in ovarian cancer - Results from the AGO-TR1-trial. Oncol. Res. Treat., 41. S. 85 - 86. BASEL: KARGER. ISSN 2296-5262